Oncology Pipeline
Various Oncology Targets
Pre-Clinical to ClinicalActive (Data presented at AACR 2026)
Key Facts
Indication
Various Oncology Targets
Phase
Pre-Clinical to Clinical
Status
Active (Data presented at AACR 2026)
Company
About Jazz Pharmaceuticals
Jazz Pharmaceuticals is a global biopharmaceutical company with a mission to develop and commercialize life-changing medicines for patients with rare diseases and unmet needs. The company has achieved significant scale with a market cap of $11.32B, a portfolio of marketed products, and a robust pipeline, driven by a sharpened strategic focus on rare diseases. Its strategy combines internal R&D with disciplined business development to build a sustainable, innovative portfolio, supported by a global commercial footprint and manufacturing infrastructure.
View full company profileTherapeutic Areas
Other Various Oncology Targets Drugs
| Drug | Company | Phase |
|---|---|---|
| Monoclonal Antibody Portfolio | Etana Biotechnologies | Preclinical |
| Switch-DARPin Platform | Molecular Partners | Discovery/Preclinical |
| Radio-DARPin Platform | Molecular Partners | Discovery/Preclinical |